an extract from another poster link...
""People are always very hesitant to try new things if they think the current therapy is working. But what I say to that is we do not know the long-term effects of MIS-C,” said Eckard.
Although it is too early to know if the novel therapy will protect against long-term complications, Eckard is heartened by the therapy’s short-term effects, which were reported in the Pediatrics article.
“There were some dramatic improvements within 24 hours of giving the treatment in both of the children, and that is what compelled us to publish those two cases,” said Eckard.
The remestemcel-L trial for use in MIS-C aims to enroll 50 children with cardiac dysfunction nationwide. If the investigational treatment proves effective at treating MIS-C, it might also be studied in children with other inflammatory syndromes.
Future studies will aim to determine if the administration of remestemcel-L is alone responsible for the improvement of patients or if it still needs to be administered with plasma antibodies, which is the current but more expensive standard of care. The current standard-of-care therapies also have unwanted side effects that might be avoided if remestemcel-L is used instead.
""
the post and link made me recall something i read about 1.5 years ago, about more kids being treated, and all survived... contained in the following...
https://web.musc.edu/about/news-center/2020/08/25/first-in-nation-treatment-for-mis-c-at-musc-shawn-jenkins-childrens-hospital
first the surival story, in 2020
But Stephens learned they could do more than that. MUSC Shawn Jenkins Children’s Hospital is the first in the country authorized to give children with MIS-C who meet certain criteria a potential treatment called remestemcel-L, brand name Ryoncil, made by Mesoblast Limited. It uses mesenchymal stromal cells from the bone marrow of healthy donors. Those cells may be able to help regulate the immune systems of children with MIS-C and repair damaged tissue.
and then this..
""The doctors said it’s important to test possible treatments, such as remestemcel-L, for MIS-C as the coronavirus pandemic continues and more children are diagnosed with MIS-C. More than a dozen children in South Carolina have been diagnosed with MIS-C so far, including seven treated at MUSC Shawn Jenkins Children’s Hospital. All survived.
"" (think i posted some of that a long while ago but worth repeating the success, part of the recall to the article said most standard care kids died, prior to reml... hence why they tried it as nothing to lose)But children in other states have not been as fortunate, Eckard said. “The CDC is reporting 11 deaths from MIS-C so far. As pediatricians, we don’t want to see any deaths in children.”(how can this not get approved!!! safe and works... FDA wants to figure out how is works..doesn't matter....safe and works)
(20min delay)